SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
ANGEL STEPHEN F

(Last) (First) (Middle)
C/O LINDE PLC
THE PRIESTLEY CENTRE, 10 PRIESTLEY ROAD

(Street)
GUILDFORD, SURREY X0 GU2 7XY

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/31/2018
3. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 2,268 I In trust for children
Ordinary Shares 68,384 I Grantor Retained Annuity Trusts
Ordinary Shares 39,285 I Angel Descendants Trust
Ordinary Shares 7,746 I 2012 Descendants Trust
Ordinary Shares 9,362.3907 I 401(k)
Ordinary Shares 171,083 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) (1) Ordinary Shares 38,270 $0(1) D
Restricted Stock Units (2) (2) Ordinary Shares 29,580 $0(2) D
Restricted Stock Units (3) (3) Ordinary Shares 47,632 $0(3) D
Restricted Stock Units (2) (2) Ordinary Shares 30,215 $0(2) D
Restricted Stock Units (3) (3) Ordinary Shares 32,580 $0(3) D
Stock Option (right to buy) (4) 02/22/2021 Ordinary Shares 218,175 $97.84 D
Stock Option (right to buy) (4) 02/28/2022 Ordinary Shares 236,510 $109.68 D
Stock Option (right to buy) (4) 02/26/2023 Ordinary Shares 187,015 $110.58 D
Stock Option (right to buy) (4) 02/25/2024 Ordinary Shares 203,930 $128.8 D
Stock Option (right to buy) (4) 02/24/2025 Ordinary Shares 261,075 $128.38 D
Stock Option (right to buy) (5) 02/23/2026 Ordinary Shares 416,355 $102.22 D
Stock Option (right to buy) (6) 02/28/2027 Ordinary Shares 435,850 $118.71 D
Stock Option (right to buy) (7) 02/27/2028 Ordinary Shares 318,780 $154 D
Deferred Stock Units (8) (8) Ordinary Shares 73,998.475 $0(9) D
Explanation of Responses:
1. Restricted Stock Units that will vest in full and payout on February 27, 2021 in Linde plc Ordinary Shares on a one-for-one basis.
2. Restricted Stock Units will vest in full and payout on February 23, 2019 in Linde plc Ordinary Shares on a one-for-one basis.
3. Restricted Stock Units that will vest in full and payout on February 28, 2020 in Linde plc Ordinary Shares on a one-for-one basis.
4. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
5. This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017.
6. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.
7. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.
8. Deferred stock units previously acquired under Praxair, Inc.'s Compensation Deferral Plan ("Deferral Plan") that will payout in Linde plc Ordinary Shares on a one-for-one basis.
9. Conversion to Linde plc Ordinary Shares is on a 1-to-1 basis.
Remarks:
Anthony M. Pepper, Attorney-in-Fact 10/31/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.